FR2132859A1 - - Google Patents

Info

Publication number
FR2132859A1
FR2132859A1 FR7212663A FR7212663A FR2132859A1 FR 2132859 A1 FR2132859 A1 FR 2132859A1 FR 7212663 A FR7212663 A FR 7212663A FR 7212663 A FR7212663 A FR 7212663A FR 2132859 A1 FR2132859 A1 FR 2132859A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7212663A
Other languages
French (fr)
Other versions
FR2132859B1 (en, 2012
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FR2132859A1 publication Critical patent/FR2132859A1/fr
Application granted granted Critical
Publication of FR2132859B1 publication Critical patent/FR2132859B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
FR7212663A 1971-04-12 1972-04-11 Expired FR2132859B1 (en, 2012)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13334271A 1971-04-12 1971-04-12
US05/555,780 US4212811A (en) 1971-04-12 1975-03-06 Bicyclic lactone intermediates

Publications (2)

Publication Number Publication Date
FR2132859A1 true FR2132859A1 (en, 2012) 1972-11-24
FR2132859B1 FR2132859B1 (en, 2012) 1976-04-16

Family

ID=26831285

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7212663A Expired FR2132859B1 (en, 2012) 1971-04-12 1972-04-11

Country Status (10)

Country Link
US (1) US4212811A (en, 2012)
JP (2) JPS5069063A (en, 2012)
BE (1) BE781979A (en, 2012)
CA (1) CA984387A (en, 2012)
CH (2) CH573384A5 (en, 2012)
DE (1) DE2217044C2 (en, 2012)
FR (1) FR2132859B1 (en, 2012)
GB (2) GB1392991A (en, 2012)
NL (1) NL163507C (en, 2012)
SE (3) SE401364B (en, 2012)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2301239A1 (fr) * 1975-02-18 1976-09-17 Upjohn Co Nouveaux analogues de prostaglandines, leur procede de preparation et medicament les contenant

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2100745A1 (en, 2012) * 1970-06-10 1972-03-24 Ono Pharmaceutical Co

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3778450A (en) * 1971-03-23 1973-12-11 Upjohn Co Certain bicyclic lactones
US3901923A (en) * 1971-03-23 1975-08-26 Upjohn Co Acylated bicyclic lactones

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2100745A1 (en, 2012) * 1970-06-10 1972-03-24 Ono Pharmaceutical Co

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2301239A1 (fr) * 1975-02-18 1976-09-17 Upjohn Co Nouveaux analogues de prostaglandines, leur procede de preparation et medicament les contenant

Also Published As

Publication number Publication date
SE418289B (sv) 1981-05-18
CH573384A5 (en, 2012) 1976-03-15
GB1392991A (en) 1975-05-07
GB1392992A (en) 1975-05-07
BE781979A (fr) 1972-10-12
JPS5069063A (en, 2012) 1975-06-09
JPS5069050A (en, 2012) 1975-06-09
US4212811A (en) 1980-07-15
SE7506373L (sv) 1975-06-04
NL163507C (nl) 1980-09-15
NL7204869A (en, 2012) 1972-10-16
FR2132859B1 (en, 2012) 1976-04-16
CH573887A5 (en, 2012) 1976-03-31
SE7700095L (sv) 1977-01-05
JPS562063B2 (en, 2012) 1981-01-17
SE401364B (sv) 1978-05-02
CA984387A (en) 1976-02-24
DE2217044A1 (de) 1972-10-26
NL163507B (nl) 1980-04-15
DE2217044C2 (de) 1985-07-11
SE401365B (sv) 1978-05-02

Similar Documents

Publication Publication Date Title
AU2658571A (en, 2012)
AU2691671A (en, 2012)
FR2132859B1 (en, 2012)
AU2742671A (en, 2012)
AU2941471A (en, 2012)
AU2726271A (en, 2012)
AU2684071A (en, 2012)
AU3005371A (en, 2012)
AU2564071A (en, 2012)
AU2894671A (en, 2012)
AU2952271A (en, 2012)
AU2885171A (en, 2012)
AU2755871A (en, 2012)
AU2940971A (en, 2012)
AU2938071A (en, 2012)
AU2930871A (en, 2012)
AU2927871A (en, 2012)
AU2486471A (en, 2012)
AU2907471A (en, 2012)
AU2963771A (en, 2012)
AU3025871A (en, 2012)
AU2880771A (en, 2012)
AU2503871A (en, 2012)
AU2875571A (en, 2012)
AU2854371A (en, 2012)

Legal Events

Date Code Title Description
ST Notification of lapse